Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (451-460 of 706) with videos related to

Pageof 71
Sort By:
Cardiovascular Therapeutics|September 3, 2011
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugsHenry Krum, Gary Swergold, Arnold Gammaitoni, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registriesMatthew T Roe, Anita Y Chen, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
JACC. Advances|December 4, 2025
GOULD EDU: Cluster-Randomized Trial of an Educational Intervention to Improve Lipid-Lowering Guideline AdherenceChristopher P Cannon, Christie M Ballantyne, Deepak L Bhatt, et al.
Journal of the American Heart Association|January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisClare Arnott, Qiang Li, Amy Kang, et al.
European Heart Journal|February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialJonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
The American Journal of Cardiology|January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarctionAjay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
The American Journal of Cardiology|November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarctionDimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
American Heart Journal|October 11, 2011
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndromeWilliam B White, George L Bakris, Richard M Bergenstal, et al.
Journal of the American Heart Association|January 13, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) TrialAlon Eisen, Christopher P Cannon, Eugene Braunwald, et al.
Pageof 71

Showing results (451-460 of 706) with videos related to

Sort By:
Pageof 71
Cardiovascular Therapeutics|September 3, 2011
Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugsHenry Krum, Gary Swergold, Arnold Gammaitoni, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registriesMatthew T Roe, Anita Y Chen, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2014
Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trialGregory Ducrocq, Phillip J Schulte, Richard C Becker, et al.
JACC. Advances|December 4, 2025
GOULD EDU: Cluster-Randomized Trial of an Educational Intervention to Improve Lipid-Lowering Guideline AdherenceChristopher P Cannon, Christie M Ballantyne, Deepak L Bhatt, et al.
Journal of the American Heart Association|January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisClare Arnott, Qiang Li, Amy Kang, et al.
European Heart Journal|February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialJonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
The American Journal of Cardiology|January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarctionAjay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
The American Journal of Cardiology|November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarctionDimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
American Heart Journal|October 11, 2011
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndromeWilliam B White, George L Bakris, Richard M Bergenstal, et al.
Journal of the American Heart Association|January 13, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) TrialAlon Eisen, Christopher P Cannon, Eugene Braunwald, et al.
Pageof 71